Clinical Trials Browser

Phase 2 × Advanced Biliary Tract Cancer × Cisplatin × Clear all

NCT06708858 2024-11-27

Phase Ⅱ Clinical Study of Surufatinib Combined With Gemcitabine and Cisplatin Plus Durvalumab/Pembrolizumab Regimen in the Treatment of Advanced Biliary Tract Cancer

Phase 2 Recruiting

Gastrointestinal

Advanced Biliary Tract Cancer

NCT05410197 2022-10-12

Envofolimab and Lenvatinib Combined With Gemcitabine Plus Cisplatin for Advanced BTC as First-Line Treatment(ENLIGHTEN)

Phase 2 Unknown

Gastrointestinal

Advanced Biliary Tract Cancer